4.8 Article

Pathogenic POGZ mutation causes impaired cortical development and reversible autism-like phenotypes

期刊

NATURE COMMUNICATIONS
卷 11, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-020-14697-z

关键词

-

资金

  1. JSPS KAKENHI [JP15H04645, JP18H02574, JP17K19488, JP17H03989, JP16K07004, JP17H05960]
  2. JSPS Research Fellowships for Young Scientists [JP17J00152]
  3. JST CREST [JPMJCR1751]
  4. MEXT KAKENHI [JP18H05416, JP19H05217, JP19H04909, JP19H05218]
  5. AMED [JP19gm1310003, JP18dm0107122, JP18dm0207061, JP18am0101084]
  6. Nagai Memorial Research Scholarship, Pharmaceutical Society of Japan
  7. Takeda Science Foundation
  8. Japan Foundation for Pediatric Research
  9. Asahi Glass Foundation
  10. Pharmacological Research Foundation, Tokyo
  11. Center for Medical Research and Education, Graduate School of Medicine, Osaka University

向作者/读者索取更多资源

Pogo transposable element derived with ZNF domain (POGZ) has been identified as one of the most recurrently de novo mutated genes in patients with neurodevelopmental disorders (NDDs), including autism spectrum disorder (ASD), intellectual disability and White-Sutton syndrome; however, the neurobiological basis behind these disorders remains unknown. Here, we show that POGZ regulates neuronal development and that ASD-related de novo mutations impair neuronal development in the developing mouse brain and induced pluripotent cell lines from an ASD patient. We also develop the first mouse model heterozygous for a de novo POGZ mutation identified in a patient with ASD, and we identify ASD-like abnormalities in the mice. Importantly, social deficits can be treated by compensatory inhibition of elevated cell excitability in the mice. Our results provide insight into how de novo mutations on high-confidence ASD genes lead to impaired mature cortical network function, which underlies the cellular pathogenesis of NDDs, including ASD.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据